Unknown

Dataset Information

0

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.


ABSTRACT: Inflammation is an evolutionary process that allows survival against acute infection or injury. Inflammation is also a pathophysiological condition shared by numerous chronic diseases. In addition, inflammation modulates important drug-metabolizing enzymes and transporters (DMETs), thus contributing to intra- and interindividual variability of drug exposure. A better knowledge of the impact of inflammation on drug metabolism and its related clinical consequences would help to personalize drug treatment. Here, we summarize the kinetics of inflammatory mediators and the underlying transcriptional and post-transcriptional mechanisms by which they contribute to the inhibition of important DMETs. We also present an updated overview of the effect of inflammation on the pharmacokinetic parameters of most of the drugs that are DMET substrates, for which therapeutic drug monitoring is recommended. Furthermore, we provide opinions on how to integrate the inflammatory status into pharmacogenetics, therapeutic drug monitoring, and population pharmacokinetic strategies to improve the personalization of drug treatment for each patient.

SUBMITTER: Stanke-Labesque F 

PROVIDER: S-EPMC7351663 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Stanke-Labesque Françoise F   Gautier-Veyret Elodie E   Chhun Stephanie S   Guilhaumou Romain R  

Pharmacology & therapeutics 20200711


Inflammation is an evolutionary process that allows survival against acute infection or injury. Inflammation is also a pathophysiological condition shared by numerous chronic diseases. In addition, inflammation modulates important drug-metabolizing enzymes and transporters (DMETs), thus contributing to intra- and interindividual variability of drug exposure. A better knowledge of the impact of inflammation on drug metabolism and its related clinical consequences would help to personalize drug tr  ...[more]

Similar Datasets

| S-EPMC7138722 | biostudies-literature
| S-EPMC7362932 | biostudies-literature
| S-EPMC7692329 | biostudies-literature
| S-EPMC8402619 | biostudies-literature
| S-EPMC3634068 | biostudies-literature
| S-EPMC5093856 | biostudies-literature
| S-EPMC8460590 | biostudies-literature
| S-EPMC9610285 | biostudies-literature
| S-EPMC8001195 | biostudies-literature
| S-EPMC6309899 | biostudies-literature